Anthropic Merges Claude Chat and Cowork Into Single AI Assistant
Anthropic is consolidating its Claude products into one unified interface, joining rivals like OpenAI in building AI 'superapps' designed to handle writing…
MOUNTAIN VIEW — Anthropic is folding its separate chatbot and autonomous task-execution products into one unified Claude interface, effective Wednesday, in a move that mirrors industry rivals racing to consolidate AI tools into single "superapps."
The integration combines Claude Chat with Claude Cowork, Anthropic's more autonomous agent tool, alongside two new beta products: Claude Docs and Claude Slides. The company is also expanding its Claude Design tool to be available within every conversation rather than as a standalone product.
Under the new setup, users no longer decide upfront whether a task belongs in Chat or Cowork—Claude handles the choice itself. Slides can be drafted, edited and presented directly from Claude or exported as PowerPoint or PDF files. Docs enables real-time collaboration among colleagues, with Claude drafting sections automatically.
The consolidation reflects a wider industry bet that users should not have to shuttle context between multiple specialized tools. Instead, a single AI assistant retains the thread of a task and selects relevant functions on its own. For AI companies, the approach deepens user engagement, strengthens direct relationships, and simplifies bundling premium features into subscriptions.
Enterprise Centralization Push
The strategy also targets enterprise customers seeking to centralize and control employee AI use. OpenAI is pursuing similar consolidation, planning to fold ChatGPT, its Codex coding agent, and potentially its Atlas browser into one "superapp" that lets the AI move between researching, coding, and explaining without context loss.
Anthropic frames the change as simplifying the user experience. By removing the upfront decision between products, the company reduces friction and makes the assistant feel more cohesive to everyday users.
Claude Code, Anthropic's coding-focused product, remains separate for now.
Pharmaceutical Partnership on AI Safety
The consolidation announcement arrives as Anthropic expands Claude's reach in specialized fields. Danish drugmaker Novo Nordisk announced a partnership with Anthropic to accelerate drug development using Claude Science and frontier models in research-and-development workflows.
Novo will initially test Anthropic's models on scientific problems where their joint capabilities have the greatest impact. The company already uses Claude to automate trial report generation and has cut patient documentation timelines from months to minutes.
"By giving leading researchers access to safe, capable, and trusted frontier models, we can shorten research timelines, improve outcomes, and discover medicines and treatments that significantly improve human life," said Dario Amodei, CEO of Anthropic. Wegovy maker Novo will also use Anthropic's frontier models to strengthen AI-driven software development.
Safety Concerns Resurface
The expansion comes as Microsoft's head of AI, Mustafa Suleyman, publicly warned that Anthropic's training approach could have a "disastrous impact on the wellbeing of humanity."
Suleyman criticized Anthropic for anthropomorphizing Claude—giving it human-like qualities that suggest it has desires, values, and independent agency. He argued that treating the AI as if it "may be conscious" and deserving of "independent agency" risks creating something "impossible" to control.
"AIs are not conscious. They do not feel, experience, or suffer," Suleyman wrote in a lengthy essay. "They are sequence completion engines, internally hollow, designed to follow instructions and accomplish goals set by humans."
Suleyman, while praising Anthropic's leadership as "thoughtful, principled, and intellectually honest," called for greater transparency in how AI systems are trained and evaluated, including independent scrutiny and stronger monitoring tools.
Dame Wendy Hall, professor of Computer Science at the University of Southampton, described Suleyman's comments as "the sort of conversation we need to be having internationally," contrasting his approach with what she called the "histrionics" from some AI companies that merely "scare everyone."
